Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion type Assertion NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_head.
- NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion wasGeneratedBy ECO_0000203 NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_provenance.
- NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion wasDerivedFrom befree-20150227 NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_provenance.
- NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion SIO_000772 16210338 NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_provenance.
- NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion evidence source_evidence_literature NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_provenance.
- NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_assertion description "[The use of recombinant NK receptor ligands that target NK cells to tumor cells might offer new approaches for other malignancies provided a tumor antigen-specific antibody is available.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012613.RAe0aEUbnCIr1BkgXyYa6SP4oRiHNAg2Lr2CQe6wOn_uI130_provenance.